key: cord-0921855-y7b1e4ko
authors: Miller, Maureen J.; Dasgupta, Sharoda; Ruffin, Jasmine; Colton, Kevin; King, David; Tate, Jacqueline E.; Kirking, Hannah L.; Bryant, Bobbi; Hennesy, Nora; Plata, Zuwena; Nakayama, Jasmine Y.; Tanner, Mary R.; Koyuncu, Aybüke; Rabold, Elizabeth
title: Severe Acute Respiratory Syndrome Coronavirus 2 Testing Trends Among Persons Aged <18 Years in an Outpatient Pediatric Practice — Metropolitan Atlanta, Georgia, May–December 2020
date: 2021-06-22
journal: J Adolesc Health
DOI: 10.1016/j.jadohealth.2021.04.010
sha: 1ac44b4d63b20c68565e59ceb1929159a9f3519f
doc_id: 921855
cord_uid: y7b1e4ko

PURPOSE: The purpose of this study was to analyze trends in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing and test positivity among persons aged <18 years in a three-site outpatient pediatric practice in Atlanta, Georgia, serving approximately 35,000 pediatric patients. METHODS: Using electronic medical records, weekly trends in SARS-CoV-2 tests performed and the 14-day moving average of test positivity were examined, overall and by age group, during May 24–December 5, 2020. RESULTS: Among 4,995 patients who received at least 1 SARS-CoV-2 test, 6,813 total tests were completed. Overall test positivity was 5.4% and was higher among older pediatric patients (<5 years: 3.3%; 5–11 years: 4.1%; 12–17 years: 8.6%). The number of tests and test positivity increased after holidays and school breaks. CONCLUSIONS: Families might benefit from communication focused on reducing SARS-CoV-2 transmission during holidays. In addition, given higher test positivity in children aged 12–17 years, tailoring public health messaging to older adolescents could help limit SARS-CoV-2 transmission risk in this population.

asymptomatic [3] . COVID-19 incidence data in children are incomplete, and testing is more frequently carried out by persons who feel sick or suspect they may have been exposed to the virus. We sought to add to the knowledge of COVID-19 incidence in children by evaluating electronic medical records from Pediatric Medical Group A (practice A), a large pediatric clinic with three locations in metropolitan Atlanta, Georgia, that serves approximately 35,000 active outpatients aged < 18 years.

Using electronic medical records from practice A, weekly trends in SARS-CoV-2 tests performed and percentage of persons who tested positive (test positivity) were examined during May 24eDecember 5, 2020. Practice A conducted SARS-CoV-2 testing with Bako RT-PCR as a send-out test from May to mid-June 2020 and with Sofia SARS Antigen Fluorescent Immunoassay/Quidel as a point-of-care test from mid-June 2020 onwards. For patients aged 0e17 years who had 1 clinical encounter during May 24e December 5, 2020 that included SARS-CoV-2 testing, demographic information, date of encounter, and test results were abstracted from the electronic medical records. Encounters were excluded if no test was performed, test results were not recorded, or only SARS-CoV-2 antibody test (without antigen or polymerase chain reaction [PCR] testing) was performed.

Among children who had encounters during the analysis period, overall number of tests and SARS-CoV-2 test positivity were examined at the person level and encounter level. For the person-level analysis, age was assigned using first date of positive SARS-CoV-2 test or first test date for all others. Mantel-Haenszel chi-square tests or Fisher's exact test was used to examine differences in SARS-CoV-2 test positivity in different groups by age, sex, and race/ethnicity (p < .05). Trends in SARS-CoV-2 test volume and positivity were examined by week (we defined "week" as the sum of all SARS-CoV-2 tests performed from Sunday (date listed on Figure) to Saturday. Practice A did not test patients on Sundays during this period.) and stratified by the age group. Test positivity was calculated based on the 14-day moving average to smooth expected variations in testing patterns and daily case counts (Calculating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Laboratory Test Percent Positivity: CDC Methods and Considerations for Comparisons and Interpretation. We defined test positivity for the personlevel analysis using the "people over people" method (number of new people with positive tests divided by the sum of the number of people with positive tests and the number of people with negative tests). We defined test positivity for the encounterlevel analysis using the "test over test" method (number of positive tests divided by the sum of the number of positive and negative tests) (Test Positivity Tracking Efforts -Johns Hopkins Coronavirus Resource Center (jhu.edu). In this analysis, 14-day moving averages for number of positive tests and number of total tests performed were calculated separately based on the past 14 days. Each moving average percent positivity value was calculated by dividing these two values.). This activity was reviewed by CDC and was conducted consistent with applicable federal law and CDC policy as part of an emergency response (see for example, 45 C. 

Of all patients with 1 encounter with an associated SARS-CoV-2 test during the analysis period (n ¼ 4,995), 31.6% were aged <5 years, 33.8% were aged 5e11 years, and 34.6% were aged 12e17 years (Table 1) . Just more than half Figure 1A) . Total tests performed decreased during August, peaked in November to >400 tests per week, and spiked after key events, including a COVID-19 outbreak associated with a Georgia camp [4] , reopening of metropolitan Atlanta schools, Fall Break, Halloween, and Thanksgiving. After May 31, the overall percentage of positive SARS-CoV-2 tests increased, peaking in July ( Figure 1B) . Throughout the analysis period, percent positivity was most frequently highest among persons aged 12e17 years.

In this outpatient pediatric practice, total tests performed and test positivity rose in the summer months, declined in the early dmetropolitan Atlanta, Georgia, May 24eDecember 5, 2020. "https://www.cdc.gov/coronavirus/2019-ncov/lab/resources/calculating-percent-positivity.html." a Calculating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) laboratory test percent positivity: CDC methods and considerations for comparisons and interpretation. We defined test positivity for the person-level analysis using the "people-over-people" method (number of new people with positive tests divided by the sum of the number of people with positive tests and the number of people with negative tests). We defined test positivity for the encounter-level analysis using the "test-over-test" method (number of positive tests divided by the sum of the number of positive and negative tests). b Weekly testing is defined as the sum of all SARS-CoV-2 tests performed from Sunday to Saturday. Pediatric Medical Group A did not test patients on Sundays during this time period. In this analysis, 14-day moving averages for number of positive tests and number of total tests performed were calculated separately based on the past 14 days. Each moving average percent positivity value was calculated by dividing these two values.

fall, and peaked in the late fall. Although testing volume was similar by the age group, SARS-CoV-2 test positivity was highest among adolescents aged 12e17 years. Test positivity increased after key events, including Halloween and Thanksgiving [1] , reflecting test positivity patterns seen in state-level COVID-19 surveillance data [5] and national claims data [6] . In another U.S. region, Hobbs et al. [7] found that children who attended activities without consistent risk mitigation had higher test positivity, highlighting how much remains unknown about how pediatric practitioners used evolving knowledge of infection risk by the age group to inform test ordering.

Practice A used CDC and AAP guidance [8, 9] and empirical experience to develop and implement its testing strategy. Many Atlanta area institutions including schools [10] and day care centers required testing before participation. Reentry guidance changed over time, necessitating a flexible testing strategy. Pediatric practitioners worked with local public health personnel to accommodate local considerations, including preactivity screening, exposure status, and symptoms [11, 12] .

These findings are subject to several limitations. First, available billing data did not provide testing indication (e.g., screening, symptoms, exposure), which might have influenced test positivity. Second, the population of practice A was primarily white, non-Hispanic, and urban. Our findings therefore might not be generalizable to other pediatric populations, and our finding that there were no differences in test positivity by racial or ethnic group had low power. Testing of 16,554 children at Texas Children's Hospital in Houston, a city where 46% of individuals identify as Hispanic or Latino, during this time period found 66% of Hispanic children (42% of all children) had positive tests [13, 14] . Third, testing volume and positivity trends might have been influenced by time of year and activity entry requirements. Although the intent of the analysis was to provide descriptive trend data by the age group, future studies should consider how trend analysis methods, including accounting for covariates other than time, might affect the observed patterns. Fourth, practice A did not perform followup testing after antigen tests were performed; recent guidance recommends follow-up testing with polymerase chain reaction in certain circumstances to minimize false-positive and false-negative results [15] . Finally, factors not discussed in this report, including local transmission patterns and use of mitigation strategies, may have impacted testing trends and test positivity.

In this practice, SARS-CoV-2 test positivity was highest among the 12-to 17-year age group and increased after holidays and school breaks. This cohort represents about 15% of practice A outpatients (4.5% aged <5 years, 4.8% aged 5e11 years, 4.9% aged 12e17 years), so these findings should be interpreted cautiously, though national trend analyses from this study period also showed higher case incidence in adolescents than in younger children [16] . As communities reopen, and children and adolescents continue to interact through school, recreational activities, and other social gatherings, the COVID-19 pandemic presents unique challenges in navigating and prioritizing social interactions, particularly among adolescents who often exercise independent decision-making [17e19]. Families might benefit from communication focused on reducing SARS-CoV-2 transmission during holidays. In addition to public health messages aimed at adults and caregivers, adolescents might benefit from tailored messaging and outreach strategies that address their developmental stage and social behaviors [20] .

American Academy of pediatrics and the Children's hospital association

Transmission of SARS-COV-2 infections in Households d Tennessee and Wisconsin, AprileSeptember 2020

Symptoms associated with a positive result for a swab for SARS-CoV-2 infection among children in

SARS-CoV-2 transmission and infection among Attendees of an Overnight camp d Georgia

School aged COVID-19 surveillance data

Assessment of 135,794 pediatric patients tested for Severe Acute Respiratory Syndrome coronavirus 2 across the United States

Factors associated with positive SARS-CoV-2 test results in outpatient health Facilities and emergency Departments among children and adolescents aged <18 Years e Mississippi

Centers for Disease Control and Prevention. CDC guidance for Expanded screening testing to reduce Silent Spread of SARS-CoV-2

COVID-19 testing guidance

COVID-19 guidance for Safe schools

Centers for Disease Control and Prevention. COVID-19 in children and Teens

Centers for Disease Control and Prevention. CDC guidance for pediatric health care Providers

A Surge in pediatric coronavirus disease 2019 cases: The experience of Texas Children's hospital from March to

American community Survey 1-year estimates, table S0201: Selected population Profile in the United States

Performance of an antigen-based test for asymptomatic and Symptomatic SARS-CoV-2 testing at two University Campuses d Wisconsin

COVID-19 trends among persons aged 0-24 Years d United States

Needs and Coping behaviors of Youth in the U.S. During COVID-19

Perspectives of US Youth during COVID-19

Adolescents' Motivations to Engage in social Distancing during the COVID-19 pandemic: Associations with mental and social health

Preexposure Prophylaxis for Prevention of HIV Acquisition among adolescents: Clinical considerations

The authors would like to acknowledge Christine M. Szablewski, D.V.M., Georgia Department of Public Health, and Faisal Saleem, Children's Medical Group of Atlanta, for their contributions to this report.

This research was supported by the U.S. Centers for Disease Control and Prevention.